PE
IDXX icon

PCM Encore’s Idexx Laboratories IDXX Stock Holding History

PCM Encore’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$367K Sell
697
-12
-2% -$6.73K 0.06% 281
2026
Q1 		$398K Buy
709
+17
+2% +$10.9K 0.08% 248
2025
Q4 		$468K Buy
+692
New +$471K 0.1% 202

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

PCM Encore's IDXX Position: Q2 2026 in Review

PCM Encore reduced its Idexx Laboratories (IDXX) stake by 1.7% in Q2 2026, selling an estimated $6.73K and leaving 697 shares worth $367K. The position accounts for 0.06% of the portfolio, ranked #281.

PCM Encore first reported a position in IDXX in Q4 2025 and has held it in 3 quarters since. The position peaked at $468K in Q4 2025. 1,298 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • PCM Encore held 697 shares of Idexx Laboratories worth $367K as of Q2 2026.
  • PCM Encore sold 12 Idexx Laboratories shares in Q2 2026, an estimated $6.73K.
  • Idexx Laboratories made up 0.06% of PCM Encore's portfolio in Q2 2026, its #281 holding.
  • PCM Encore first reported a position in Idexx Laboratories in Q4 2025 and has held it in 3 quarters since.
  • PCM Encore's Idexx Laboratories position peaked at $468K in Q4 2025.
  • 1,298 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on PCM Encore's 13F filing for Q2 2026, filed 11 Aug 2026.